Incyte Corp.

NAS: INCY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204510994/composite

$

101.75

Change

0.00 0.00%

Volume

Volume 19,401

Jun 1, 2020, 4:02 p.m.

Real time quotes

/zigman2/quotes/204510994/composite

Today's close

$ 101.91

$ 101.75

Change

-0.16 -0.16%

Day low

Day high

$100.52

$102.58

Open
Open: 101.70

52 week low

52 week high

$62.48

$104.81

Open

Market cap

$22.15B

Average volume

1.91M

P/E ratio

N/A

Rev. per Employee

$1.38M

EPS

-1.74

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/incy

MarketWatch News on INCY

  1. Incyte downgraded to neutral from overweight at J.P. Morgan

    6:48 a.m. May 6, 2020

    - Tomi Kilgore

  2. Activision Blizzard’s Play for a Pandemic Premium

    6:19 a.m. May 2, 2020

    - Barron's Online

  3. Incyte, Novartis launch drug study to treat coronavirus complication

    4:49 p.m. April 17, 2020

    - Wallace Witkowski

  4. A Blood Test That Could Get America Back to Work

    2:47 p.m. April 4, 2020

    - Barron's Online

  5. Incyte stock price target cut to $85 from $99 at Oppenheimer

    10:07 a.m. March 25, 2020

    - Tomi Kilgore

  6. The U.S. Is Coming Up Short in Its Response to Coronavirus

    12:49 p.m. March 14, 2020

    - Barron's Online

  7. 20 Years Later, Tech Bubble Still Offers Lessons for Investors

    9:30 p.m. March 13, 2020

    - Barron's Online

  8. Hedge Funds Bought Uber, Exxon Mobil, and Nvidia Last Quarter

    2:26 p.m. Feb. 25, 2020

    - Barron's Online

  9. Incyte stock price target raised to $116 from $111 at Instinet

    12:47 p.m. Feb. 19, 2020

    - Tomi Kilgore

  10. Incyte Climbs After Reporting a ‘Solid Quarter and Guidance’

    10:01 a.m. Feb. 13, 2020

    - Barron's Online

  11. Loading more headlines...
/news/nonmarketwatch/company/us/incy

Other News on INCY

  1. MorphoSys up 3% on long-term tafasitamab data in blood cancer

    12:04 p.m. May 14, 2020

    - Seeking Alpha

  2. Biotech's Golden Moment As Healthcare Attracts Investors

    9:31 a.m. May 12, 2020

    - Seeking Alpha

  3. Optimism Runs High for MacroGenics

    9:14 a.m. May 11, 2020

    - GuruFocus.com

  4. FDA OKs Novartis' Tabrecta for certain lung cancer patients

    3:26 p.m. May 6, 2020

    - Seeking Alpha

  5. Incyte (INCY) Receives a Hold from Credit Suisse

    11:58 a.m. May 6, 2020

    - SmarterAnalyst

  6. Nomura Keeps Their Buy Rating on Incyte (INCY)

    10:15 a.m. May 6, 2020

    - SmarterAnalyst

  7. Company News for May 6, 2020

    9:46 a.m. May 6, 2020

    - Zacks.com

  8. Loading more headlines...
/news/pressrelease/company/us/incy

Press Releases on INCY

  1. Incyte to Present at Upcoming Investor Conference

    8:00 a.m. May 21, 2020

    - BusinessWire - BZX

  2. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.